Medicare Part D Plan Availability and Enrollment Trends Following the 2025 Benefit Redesign

IPD Analytics has released a new report, “Medicare Part D Plan Availability and Enrollment Trends Following the 2025 Benefit Redesign.”

The Inflation Reduction Act of 2022 fundamentally restructured the Medicare Part D benefit, introducing an annual out-of-pocket cap for beneficiaries ($2,000 in 2025 and $2,100 in 2026) while shifting greater cost responsibility to plan sponsors and manufacturers. As the Center for Medicare & Medicaid Services (CMS) will phase out the 2025 Premium Stabilization Demonstration after Contract Year 2026, the return to more standard Part D risk-sharing is expected to increase plan sponsors’ financial exposure and influence premiums, plan availability, and market dynamics across both stand-alone prescription drug plans (PDPs) and Medicare Advantage Prescription Drug (MAPD) plans.

This report examines how the 2025 benefit redesign has already begun reshaping the Part D landscape, including changes in plan availability, sponsor market participation, and enrollment movement as sponsors reassess PDP and MAPD offerings in response to heightened financial risk.

Key themes explored in this report include the shift in catastrophic-phase liability to plan sponsors and manufacturers, strategic repositioning across PDP and MAPD products, continued PDP premium and bid pressure, and changes in broker compensation and distribution strategy.

For payers, manufacturers, and other stakeholders navigating the post-redesign environment, this report provides essential context and directional insights to inform planning and strategy.

Content on this site is proprietary to IPD Analytics. This sample is not for distribution. By receiving it, you agree to refrain from any unauthorized use, including uploading or inputting it into AI tools or large language models (LLMs) for training or any other purpose. This is strictly prohibited.